Internal Medicine · Rockville Centre, NY
NPI
1124024336
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
371 Merrick Rd, Ste 302
Rockville Centre, NY, 11570
Phone (516) 678-5555
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
21,202 services
Medicare patients, 2024
1,363
Average age 78
Drug cost, 2024
$2.1M
16,163 prescriptions
Company payments, 2025
$4,158
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farid Shahkoohi was code 99308 (snf e&m), 4,789 times for 341 patients. In total Farid Shahkoohi billed 21,202 services in 100 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 4,789 | 341 | $61.69 | $295K |
| 99232 Hospital E&M - Subsequent | Facility | 3,284 | 473 | $64.98 | $213K |
| 99458 E&M - Miscellaneous | Office | 1,351 | 130 | $32.94 | $45K |
| 99457 E&M - Miscellaneous | Office | 1,111 | 151 | $41.21 | $46K |
| 99212 Office E&M - Established | Office | 1,066 | 444 | $46.46 | $50K |
| 99214 Office E&M - Established | Office | 1,060 | 421 | $102.13 | $108K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 944 | 156 | $52.23 | $49K |
| 99454 E&M - Miscellaneous | Office | 722 | 117 | $41.22 | $30K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 504 | 119 | $40.05 | $20K |
| 99213 Office E&M - Established | Office | 453 | 241 | $74.68 | $34K |
| 36415 Venipuncture Blood Collection | Office | 423 | 258 | $8.67 | $3,667 |
| 99223 Hospital E&M - Initial | Facility | 363 | 302 | $142.84 | $52K |
| 99291 Critical Care E&M | Facility | 362 | 51 | $176.40 | $64K |
| 99233 Hospital E&M - Subsequent | Facility | 343 | 145 | $97.71 | $34K |
| 99497 Care Management/Coordination | Office | 308 | 290 | $63.75 | $20K |
By year: 2022 $665K for 9,350 services; 2023 $850K for 11,998 services; 2024 $1.3M for 21,202 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 423 | 258 | $8.67 | $3,667 |
| 87880 Immunoassay | 126 | 96 | $16.61 | $2,093 |
| 87426 Immunoassay | 125 | 95 | $34.91 | $4,363 |
| 87631 Infectious Agent Detection by DNA/RNA | 115 | 87 | $134.89 | $16K |
| 81002 Clinical Chemistry | 13 | 12 | $3.41 | $44.33 |
| 87804 Immunoassay | 13 | 13 | $16.22 | $211 |
Medicare prescription drug claims, 2024
In 2024, the drug Farid Shahkoohi prescribed most often to Medicare patients was Atorvastatin Calcium, with 928 prescriptions and refills. In total Farid Shahkoohi wrote 16,163 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 928 | 2,288 | 342 | $9,904 |
| Amlodipine Besylate Generic | 555 | 1,329 | 227 | $3,702 |
| Levothyroxine Sodium Generic | 454 | 988 | 164 | $7,532 |
| Rosuvastatin Calcium Generic | 405 | 1,090 | 165 | $7,020 |
| Metoprolol Succinate Generic | 284 | 666 | 129 | $5,279 |
| Escitalopram Oxalate Generic | 266 | 625 | 100 | $3,559 |
| Furosemide Generic | 262 | 357 | 116 | $1,294 |
| Alprazolam Generic | 256 | 256 | 62 | $1,680 |
| Eliquis Apixaban | 255 | 354 | 82 | $168K |
| Gabapentin Generic | 234 | 352 | 94 | $4,788 |
| Metformin Hcl Generic | 234 | 562 | 99 | $1,736 |
| Losartan Potassium Generic | 221 | 450 | 87 | $2,327 |
| Sodium Chloride 0.9 % Sodium Chloride | 215 | 215 | 96 | $4,773 |
| Tamsulosin Hcl Generic | 201 | 385 | 97 | $3,657 |
| Pantoprazole Sodium Generic | 194 | 364 | 98 | $5,373 |
Brand drugs: 2,588 claims; generic drugs: 13,501 claims; opioid claims: 113.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farid Shahkoohi $4,158 ($4,158 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $536.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $536 |
| Amgen Inc. AMGN | 10 | $462 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $345 |
| Novo Nordisk Inc NVO | 17 | $278 |
| Pfizer Inc. PFE | 10 | $237 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $230 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $230 |
| GlaxoSmithKline, LLC. GSK | 11 | $216 |
| MIMEDX Group, Inc. MDXG | 1 | $179 |
| Genzyme Corporation SNY | 7 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.